Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

CSB601 > Week 4: Respiratory - Asthma, COPD, Nicotine Cessation > Flashcards

Week 4: Respiratory - Asthma, COPD, Nicotine Cessation Flashcards

1
Q

What is the pathophysiology of asthma?

A

Asthma causes the stimulation of IgE antibodies which causes mast cell activation or degranulation - leads to inflammation and mucus production causing the flare of asthma

Acute inflammation - symptoms (bronchoconstriction)
Chronic inflammation - exacerbations nonspecific hyperreactivity
Airway remodeling - persistent airflow obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms of Asthma

A

Symptoms include

  • Increase mucus production
  • Thickened bronchial walls
  • Wheeze
  • Shortness of breath
  • Chest tightness
  • Cough
  • Expiratory airflow limitation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pathophysiological effects of asthma attack

A
  • Altered immunological response -> chemical mediators released (histamine, protaglandins, bradykinins etc.
  • Increased airway resistance -> mucus secretion, inflammation, bronchospasm
  • Increased lung compliance -> lungs become hyper-inflated
  • Impaired mucocillary function -> increased mucus production (can cause cough)
  • Altered O2-CO2 exhcange -> increased airway resistance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Asthma effect on airways

A

Asthmatic airway during attack

- Tightned smooth muscles, wall inflamed and thickened, enlarged alveolar as air is trapped

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How to control asthma?

  • Good control
  • Partial control
  • Poor control
A

Good control (all of following)

  • Daytime symptoms <2 days per week
  • Need for reliever <2 days per week
  • No limitation of activities
  • No symptoms during night or on waking

Partial control (one or two of following)

  • Daytime symptoms >2 days per week
  • Need for reliever >2 days per week
  • Any limitation of activities
  • Any symptoms during night or on waking

Poor control (three or more of following)

  • Daytime symptoms >2 days per week
  • Need for reliever >2 days per week
  • Any limitation of activity
  • Any symptoms during night or on waking
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lifestyle management of ashma

A
  • Smoking cessation (including second degree)
  • Identify and avoid triggers
  • Manage comorbidities
  • Healthy eating and body weight
  • Regular physical activity
  • Regular immunisations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmaceutical management options for asthma

A

Short acting beta agonist (SABA)

Long acting beta agonist (LABA)

Inhaled corticosteroids (ICS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

SABA

  • MOA
  • Clinical use
  • Drug options
A

MOA

  • Agonist of beta-2-adrenergic receptors in lungs
  • Cause bronchodilation by relaxing bronchial smooth muscle and allowing airway to open

Clinical use

  • Relievers
  • Used as needed to relieve symptoms
  • May be used before exercise
  • Rapid onset 3-4 min
  • Duration of 3-4 hrs

Drug options

  • Salbutamol (Ventolin, Asmol)
  • Terbutaline (Bricanyl)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Contraindications/Cautions of SABA

A

Pregnancy/Breastfeeding/Heptic impairment/Renal impairment
- Safe

Elderly:
- Start with low dose and slowly titrate

Children:
- Safe for children aged 2+ (need specialist if younger)

Cautions in:

  • CVD
  • Hyperthyroidism
  • Diabetes
  • History of PACG
  • Other sympathomimetics
  • Corticosteroids
  • Theophyline
  • Diuretics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

LABA

  • MOA
  • Clinical use
  • Drug options
A

MOA

  • Agonist of beta 3 adrenergic receptors
  • Activate receptors in bronchial smooth muscles to allow relaxation and bronchodilation

Clinical use
- Preventor

Drug options

  • Salmeterol (Serevent, Seretide)
  • Eformoterol (Oxis, Symbicort)
  • Indacaterol (Onbrez)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Contraindications/cautions of LABA

A

Hepatic and renal impairment
- No precautions

Elderly:
- Start low dose and slowly titrate

Pregnancy:
- Limited data

Breastfeeding:
- Salmeterol is safe

Children:
- Safe for children 2+ (specialist if younger)

Cautions in:

  • CVD
  • Hyperthyroidism
  • Diabetes
  • History of PACG
  • Other sympathomimetics
  • Corticosteroids
  • Theophyline
  • Diuretics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ICS

  • MOA
  • Clinical use
  • Drug options
A

MOA

  • Immunosuppressant
  • Reduce airway inflammation and bronchial hyper-reactivity

Clinical use

  • Maintenance therapy
  • Can be combined with LABA or given on its own
  • Useful for prevention even if only occasional flare up

Drug options

  • Beclomethasone (QVAR)
  • Budesonide (Pulmicort)
  • Fluticasone (Flixotide, Breo)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Contraindications/cautions for ICS

A

Pregnancy/breastfeeding/hepatic impairment/renal impairment:
- Safe and no precautions

Elderly:

  • More susceptible to skin thinning and bruising
  • Use lower dose

Children:
- Avoid high dose without specialist involvement

Cautions in:
- COPD (pneumonia risk)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Inhaled Anticholinergics

  • MOA
  • Clinical use
  • Drug options
A

MOA

  • Antagonist of cholinergic receptors in bronchial tissue
  • Relax smooth muscle to allow bronchodilation
  • Specifically antagonise the muscarinic effects of cholingeric receptors (also referred to as SAMA or LAMA)

Clinical use:

  • Short acting (SAMA) -> relief of asthma symptoms
  • Long acting (LAMA) -> maintenance/prevention of asthma symptoms in combination with LABA or ICS

Drug options

  • Short acting -> Ipratropium
  • Long acting -> Tiotripium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Contraindications/Cautions of inhaled anticholingeric

A

Pregnancy/Breastfeeding/Hepatic impairment/Renal impairment:
- Safe and no cautions

Elderly:
- Likely to be susceptible to urinary retension

Children:

  • SAMA can be used
  • LAMA’s cannot

Caution in:
- Bladder obstruction/urinary retension or PACG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Device techniques for asthma

A

MDI - metered dose inhaler (under pressure)
DPI - dry powder inhaler (uses inspiration of patients)
Nebules - liquids that are suspended and inhaled via nebuliser
Oral capsule
Spacers - greatly increase amount of dose MDIs reachs lungs

17
Q

Asthma Management plan

A

Do they have one?
Are there copies?
Do they know what to do in an attack?

18
Q

What is COPD?

A

Chronic obstructive pulmonary disease
- Umbrella term describing progressive lung diseases including emphysema, chronic bronchitis, refractory asthma and bronchiectasis

All of which are characterised by increasing breathlessness

19
Q

COPD Pathophysiology

A

Chronic inflammation causing damage to lung elasticity therefore over-expanded lungs make it difficult to breath out fully
Chronic over-expansion leads to more air trapped causing hyperinflation and muscles have to work harder thus require more oxygen
Chronic inflammation also causes narrowing of airways and excess sputum which further restricts airflow

20
Q

The cycle of inactivity

A
  • Shortness of breath and difficulty with day-day activities
  • Poor confidence and less physical activity
  • Muscles loose strength and heart function decreases
  • Fitness declined and social isolation
  • Worse shortness of breath as well as anxiety or depression
  • Loss of independence and symptoms worsen
21
Q

Complications of COPD

A
  • Increased susceptibility to chest infection
  • Pneumothorax
  • CVD
  • Anxiety/depression
  • Oedema
  • Hypoxaemia
  • Obesity
  • Osteoporosis
  • Death
22
Q

Lifestyle modifications for COPD

A
  • Smoking cessation
  • Maintain healthy weight
  • Regular, appropriate exercise to improve CV fitness
  • Breathing techniques
    > Pulmonary rehabilitation (Relaxed breathing, prolonged expiration breathing, recovery position)
  • Manage anxiety
  • Manage comorbidities (infection, regular vaccines, BP)
23
Q

1st line drug therapy for COPD

A

For exacerbations of breathlessness, patients are almost always started on either
- SABA (short acting beta2 agonist - salbutamol, terbutaline)
SAMA (short acting muscarinic antagonist - ipratropium)

24
Q

2nd line drug therapy for COPD

A

Used if SABA or SAMA are not enough to control exacerbation

  • LABA (Long acting beta2 agonist - salmeterol or eformoterol)
  • Ultra LABA (ultra long acting - indacaterol
  • LAMA (long acting muscarinic antagonist - tiotropium)
25
Q

3rd line drug therapy for COPD

A

Combination of 1st and 2nd line drugs

  • LAMA + LABA
  • ICS + LABA
  • ICS + LAMA (no single inhaler device available = less compliance)
  • ICS are not indicated for single use in COPD
26
Q

Drug therapy as COPD progresses

A

Oxygen therapy
- For patients with significant hypoxaemia or presenting 18hrs/day

Theophylline
- Lots of contraindications and requires lots of monitoring

Mucolytics

Long term low dose antibiotics (infections that cause exacerbation in late stage)

27
Q

Nicotine Pharmacology

  • Half life
  • Metabolism
  • Distribution/Duration
A

Nicotine is colorless and odorless

Half life <40 min

Nicotine receptors (nACh) in liver are quickly unregulated therefore a higher dose is needed to achieve the same effect 
Metabolism changes between individuals - CYP4502A6 enzyme

Inhalation results in very rapid (within 10 sec) distribution within CNS however, it also rapidly declines inducing withdrawal (use regularly to keep dopamine levels up and minimize withdrawal)

28
Q

Definition of addiction

- Nicotine

A

Addiction is chronic, relapsing brain disease that is characterized by compulsive drug seeking and use despite harmful consequences

Nicotine is a highly addictive substance

  • Poisonous plant alkaloid found in tobacco
  • Ingestion/inhalation results in activation of the reward pathway (dopamine in mesolimbic pathway)
29
Q

The ‘good’ effects of nicotine

A

Activates many different neurotransmitters

  • Dopamine -> pleasure, appetite suppression
  • NA -> arousal, appetite suppression
  • Ach -> arousal, cognitive enhancement
  • Vasopressin -> memory improvement
  • 5HT -> mood enhancement, appetite suppression
  • Beta-endorphines -> reduction in tension and anxiety
30
Q

Why is it so difficult to quit smoking?

A 
Withdrawal symptoms 
- Physiological addiction
- Emotional addiction
Fear of failure
Social pressure
Unwanted side effects of quitting 
- Weight gain
- Stress
- Increased addiction to alcohol, food
Lack of compliance with medications/quitting aids/CBT
31
Q

Nicotine withdrawal symptoms

A
  • Craving
  • Irritability/restlessness
  • Sleep disturbances
  • Headache
  • Depression
  • Anxiety
  • Difficulty concentrating
  • Increased appetite
  • Constipation
32
Q

Smoking health outcomes - increased risk of other health conditions

A
  • Mortality (premature death with 10 cigarettes per day doubling the risk)
  • CVD
  • Asthma/COPD/Emphysema/Pneumonia
  • Premature aging
  • Staining of skin and teeth
  • Peridontal disease (gum disease)
  • Cancer
  • Diabetes
  • Ostoporosis/RA
  • Sexual dysfunction/infertility/still birth/premature birth
  • Blindness/Cataracts
33
Q

Physiological changes timeline as someone quits

A
  • 20 min (return normal BP, HR, temp)
  • 8 hrs (O2 level normal)
  • 24 hrs (decreased chance of heart attack)
  • 48 hrs (taste and smell begin to improve)
  • 1 month (immune system begins to recover)
  • 1-3 months (circulation to extremities return)
  • 3 months (lung function begins to normalize)
  • 1 yr (50% reduction in risk of heart attack)
  • 5 yrs (risk of stroke returns to non smoker level)
  • 10 yrs (risk of lung cancer reduced by 30-50%)
  • 15 yrs (CVD risk almost back to non smoker level)
34
Q

Nicotine replacement therapy (NRT)

  • Inhalation
  • Oral/Buccal
  • Transdermal
A

Aim to decreased withdrawal/cravings and increase success rate

Inhalations
- e-cigarettes, inhalers
- Fast delivery
Oral/Buccal
- Moderate fast
- Strip, mist, lozenges, gum
Transdermal
- Slowest
- Patches
35
Q

NRT approaches

- First line

A

First line
- Combination of NRT products

Pre quit patches

  • Helps reduce anxiety around quitting
  • Reduce no. cigarettes smoked therefore reduced toxins

Reduced no. to quit in combination with NRT

36
Q 
Pharmacotherapy for smoking cessation:
Varenicline (Champix)
- MOA
- ADR
- Practice points
A

MOA

  • Partial agonist at nACh receptor
  • Blocks nicotine from binding - stops pleasurable effects of smoking
  • Partial agonist - reduced sx of withdrawal

ADR

  • Commonly causes sleep disturbances (vivid dreams, nightmares and nausea)
  • May cause depression, agitation, behavior changes, suicidal idealization (rare)

Practice point
- Needs to be started at least 7 days before trying to quit

37
Q

Pharmacotherapy for smoking cessation:
Varenicline (Champix)
- Contraindications and cautions

A

Hepatic impairment
- Can raise liver enzymes

Pregnancy
- No data - avoid

Breastfeeding
- No data

Renal impairment
- Reduce dose

Caution in history of seizures

38
Q

Pharmacotherapy for smoking cessation:
Bupoprion (Zyban)
- MOA
- Practice point

A

MOA

  • Unknown for smoking cessation
  • It inhibits re uptake of dopamine and noradrenaline

Practice point
- Needs to be started at least 7 days before trying to quit

39
Q

Pharmacotherapy for smoking cessation:
Bupoprion (Zyban)
- Contraindications and cautions

A

Elderly
- Reduce dose

Hepatic impairment

  • Reduce dose
  • Contraindicated in severe impairment

Pregnancy
- Avoid

Breastfeeding
- Appears safe

Renal impairment
- Reduce dose

Contraindicated in bipolar or tx with MAOI within 14 days, seizures, CNS tumor, bulimia, anorexia

CSB601 (12 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions